Related references
Note: Only part of the references are listed.Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor
Shuming Yin et al.
SCIENCE CHINA-LIFE SCIENCES (2022)
Inference of CRISPR Edits from Sanger Trace Data
David Conant et al.
CRISPR JOURNAL (2022)
Gene editing and its applications in biomedicine
Guanglei Li et al.
SCIENCE CHINA-LIFE SCIENCES (2022)
CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs
Jiahuan Chen et al.
HAEMATOLOGICA (2021)
In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia
Huan Zhao et al.
CIRCULATION (2020)
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
Jordan L. Doman et al.
NATURE BIOTECHNOLOGY (2020)
A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I
Li Ou et al.
MOLECULAR THERAPY (2020)
Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing
Lei Yang et al.
MOLECULAR THERAPY (2020)
CRISPR-Cas9-Mediated In Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice
Qingnan Wang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1
Rui Zheng et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Anthony Conway et al.
MOLECULAR THERAPY (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Optimizing genome editing strategy by primer-extension-mediated sequencing
Jianhang Yin et al.
CELL DISCOVERY (2019)
CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX-knockout mice
Lili Wang et al.
BLOOD (2019)
Gene Therapy
Katherine A. High et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction
Keiichiro Suzuki et al.
CELL RESEARCH (2019)
Update on clinical gene therapy for hemophilia
George Q. Perrin et al.
BLOOD (2019)
Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse
Jian-Ping Zhang et al.
GENOME BIOLOGY (2019)
Droplet digital PCR improves absolute quantification of viable lactic acid bacteria in faecal samples
Guillaume Gobert et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2018)
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
Kanut Laoharawee et al.
MOLECULAR THERAPY (2018)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L. A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy
Xiaohui Zhang et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
Tsukasa Ohmori et al.
SCIENTIFIC REPORTS (2017)
Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model
Fabiola Porro et al.
EMBO MOLECULAR MEDICINE (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Homology-mediated end joining-based targeted integration using CRISPR/Cas9
Xuan Yao et al.
CELL RESEARCH (2017)
Error-Prone Repair of DNA Double-Strand Breaks
Kasey Rodgers et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse
Yuting Guan et al.
EMBO MOLECULAR MEDICINE (2016)
The F8-/- rat as a model of hemophilic arthropathy
K. R. Sorensen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
Thomas Gaj et al.
MOLECULAR THERAPY (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang et al.
NATURE BIOTECHNOLOGY (2016)
Genetic Targeting of the Albumin Locus to Treat Hemophilia
Andrew M. Davidoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Rajiv Sharma et al.
BLOOD (2015)
Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9
Chul-Yong Park et al.
CELL STEM CELL (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Promoter less gene targeting without nucleases ameliorates haemophilia B in mice
A. Barzel et al.
NATURE (2015)
A novel F8-/- rat as a translational model of human hemophilia A
L. N. Nielsen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos
Yanjiao Shao et al.
NATURE PROTOCOLS (2014)
Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9
Shota Nakade et al.
NATURE COMMUNICATIONS (2014)
Robust ZFN-mediated genome editing in adult hemophilic mice
Xavier M. Anguela et al.
BLOOD (2013)
Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining
Marcello Maresca et al.
GENOME RESEARCH (2013)
Hepatic Gene Transfer in Neonatal Mice by Adeno-Associated Virus Serotype 8 Vector
Lili Wang et al.
HUMAN GENE THERAPY (2012)
Retake the Center Stage - New Development of Rat Genetics
Sushuang Zheng et al.
JOURNAL OF GENETICS AND GENOMICS (2012)
Generation and Characterization of Severe Combined Immunodeficiency Rats
Tomoji Mashimo et al.
CELL REPORTS (2012)
In vivo genome editing restores haemostasis in a mouse model of haemophilia
Hojun Li et al.
NATURE (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
AAV2/8-mediated Correction of OTC Deficiency Is Robust in Adult but Not Neonatal Spfash Mice
Sharon C. Cunningham et al.
MOLECULAR THERAPY (2009)
DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells
Zhiyong Mao et al.
CELL CYCLE (2008)
A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice
Claudia Mitchell et al.
NATURE PROTOCOLS (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
Adeno-associated virus vectors integrate at chromosome breakage sites
DG Miller et al.
NATURE GENETICS (2004)
Share Paper
